suffering from a disease state wherein the polymeric immunoglobulin receptor is expressed, such antibodies comprising antibodies that will neutralize one or more growth factors associated with the disease state, or their receptors, in order to diminish the onset, progression, and growth of diseased tis...
Dialysis and Transplantation Current therapy for ADPKD and ARPKD patients who have reached end-stage renal disease is limited to dialysis and transplantation. The treatment of dual-organ involvement in ARPKD has traditionally focused first on the renal com- plications and sequentially on hepatobiliary ...
Polycystic kidney disease (PKD) is a condition marked by the formation of cysts in the kidney. In some cases, the sac-like cysts can also be seen in the pancreas, liver, and spleen. It is one of the most common genetic disorders, running in the families and a common cause of kidney ...
Polycystic Kidney Disease (PKD) - Learn about the causes, symptoms, diagnosis & treatment from the Merck Manuals - Medical Consumer Version.
Find all the latest on polycystic kidney disease at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
Chronic Kidney Disease : Symptoms and Diagnosis + Chronic Kidney Disease : Treatment + Dialysis + Kidney Transplantation Other Major Kidney Diseases + Diabetic Kidney Disease + Polycystic Kidney Disease + Living with a Single Kidney + Urinary Tract Infection + Stone Disease + Benign Prostatic Hyperplas...
sequenced; new experimental models and the application of molecular biology techniques have provided new insights into the pathogenesis R polycystic kidney disease; novel clinical studies have provided valuable information for the prevention, evaluation, and treatment of the complications of this disease. ...
Autosomal dominant polycystic kidney disease: pathophysiology and treatment Autosomal dominant polycystic disease (ADPKD) is one of the most common monogenic disorders, and globally is the third most common cause of end-stage kidne... J Rapoport - 《Qjm Monthly Journal of the Association of Physician...
E. et al. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N. Engl. J. Med. 377, 1930–1942 (2017). CAS PubMed Google Scholar Lanktree, M. B. & Chapman, A. B. New treatment paradigms for ADPKD: moving towards precision medicine. Nat. Rev. Nephrol. 13, 750...
PKD Foundation — We give hope. We fund research, advocate for patients, and build a community for all impacted by polycystic kidney disease. #endPKD